National Health Investors, Inc.

Equities

NHI

US63633D1046

Specialized REITs

Market Closed - Nyse 04:00:02 2024-04-15 pm EDT 5-day change 1st Jan Change
59.05 USD +1.08% Intraday chart for National Health Investors, Inc. -3.21% +5.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT
North American Morning Briefing : Stock Futures -2- DJ
BMO Capital Upgrades National Health Investors to Outperform From Market Perform MT
National Health Investors Insider Bought Shares Worth $586,882, According to a Recent SEC Filing MT
North American Morning Briefing : Stock Futures -2- DJ
National Health Investors Shares Rise After Wells Fargo, Wedbush Upgrade MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63 MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55 MT
Wedbush Upgrades National Health Investors to Outperform From Neutral, Says More Optimistic on Skilled Nursing Facilities/Senior Housing; Raises PT to $64 From $57 MT
Transcript : National Health Investors, Inc., Q4 2023 Earnings Call, Feb 21, 2024
National Health Investors' Q4 Normalized FFO, Revenue Rise; 2024 Outlook Issued MT
Earnings Flash (NHI) NATIONAL HEALTH INVESTORS Reports Q4 Revenue $79.5M MT
National Health Investors, Inc. Provides Earnings Guidance for the Year 2024 CI
National Health Investors, Inc. Announces First Quarter Dividend, Payable on May 3, 2024 CI
National Health Investors, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Tranche Update on National Health Investors, Inc.'s Equity Buyback Plan announced on February 21, 2023. CI
National Health Investors, Inc. announces an Equity Buyback for $160 million worth of its shares. CI
National Health Investors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on National Health Investors, Inc.'s Equity Buyback Plan announced on February 21, 2023. CI
National Health Investors, Inc.'s Equity Buyback announce on February 21, 2023, has expired with 0 shares, representing 0% for $0 million. CI
National Health Investors, Inc. authorizes a Buyback Plan. CI
Deutsche Bank Initiates Coverage on National Health Investors With Buy Rating, $69 Price Target MT
Wells Fargo Adjusts National Health Investors' Price Target to $55 From $54, Maintains Equal-Weight Rating MT
Transcript : National Health Investors, Inc., Q3 2023 Earnings Call, Nov 08, 2023
National Health Investors Q3 Normalized Funds From Operations, Revenue Rise; 2023 Outlook Cut MT
Chart National Health Investors, Inc.
More charts
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
59.05 USD
Average target price
62.83 USD
Spread / Average Target
+6.41%
Consensus
  1. Stock Market
  2. Equities
  3. NHI Stock
  4. News National Health Investors, Inc.
  5. Wells Fargo Adjusts Price Target on National Health Investors to $54 From $52, Maintains Equalweight Rating